Febuxostat
Showing 1 - 25 of 106
Gout Trial in Incheon (Epaminurad 6 mg, Epaminurad 9 mg, Febuxostat 40 mg)
Recruiting
- Gout
- Epaminurad 6 mg
- +7 more
-
Incheon, Korea, Republic ofInha University Hospital
Apr 4, 2023
Gout With Hyperuricemia in Adults Trial (HR091506 tablets + of febuxostat tablets, febuxostat tablets + of HR091506 tablets)
Not yet recruiting
- Gout With Hyperuricemia in Adults
- HR091506 tablets + placebo of febuxostat tablets
- febuxostat tablets + placebo of HR091506 tablets
- (no location specified)
Nov 15, 2023
Primary Gout and Hyperuricemia Trial (SHR4640 tablet, febuxostat tablet, SHR4640 tablet)
Not yet recruiting
- Primary Gout and Hyperuricemia
- SHR4640 tablet
- +2 more
- (no location specified)
Aug 22, 2022
Drug Interaction Trial in Seoul (Methotrexate Sodium, Rifampicin Sodium, Febuxostat Tablets)
Completed
- Drug Interaction
- Methotrexate Sodium
- +2 more
-
Seoul, Korea, Republic ofSeoul National University Bundang Hospital
Oct 10, 2022
Non Alcoholic Steatohepatitis, Hyperuricemia Trial in Tanta (Febuxostat 80 MG Oral Tablet, vit E)
Recruiting
- Non Alcoholic Steatohepatitis
- Hyperuricemia
- Febuxostat 80 MG Oral Tablet
- vit E
-
Tanta, EgyptDepartment of Tropical Medicine and Infectious Diseases, Faculty
Oct 8, 2022
Non-Alcoholic Fatty Liver Disease, Hyperuricemia Trial (Allopurinol (100 mg/day) plus lifestyle intervention, Febuxostat 40 mg
Not yet recruiting
- Non-Alcoholic Fatty Liver Disease
- Hyperuricemia
- Allopurinol (100 mg/day) plus lifestyle intervention
- +2 more
- (no location specified)
Jul 23, 2022
Gout Trial in Qingdao (Colchicine)
Recruiting
- Gout
-
Qingdao, Shandong, ChinaThe Affiliated Hospital of Qingdao University
May 6, 2022
Chronic Kidney Disease stage3, Contrast-induced Nephropathy Trial in Cairo (Isotonic saline, N-acetyl cysteine, Febuxostat 80
Completed
- Chronic Kidney Disease stage3
- Contrast-induced Nephropathy
- Isotonic saline
- +2 more
-
Cairo, EgyptAin shams university hospitals
Mar 10, 2022
Primary Gout With Hyperuricemia in Adults Trial (HR091506 tablets + of febuxostat tablets, febuxostat tablets + of HR091506
Not yet recruiting
- Primary Gout With Hyperuricemia in Adults
- HR091506 tablets + placebo of febuxostat tablets
- febuxostat tablets + placebo of HR091506 tablets
- (no location specified)
Apr 21, 2022
Gout, CKD Stage 1-4, SUA Level (>8 mg/dL; 480 µmol/L) Trial in Kiev (Febuxostat 80 MG Oral Tablet or Allopurinol 300 MG Oral
Enrolling by invitation
- Gout
- +2 more
- Febuxostat 80 MG Oral Tablet or Allopurinol 300 MG Oral Tablet
-
Kiev, UkraineMedical Practice Prof D.Ivanov
Aug 22, 2022
Gout Trial in Taipei (Placebo, AC-201, Febuxostat)
Completed
- Gout
- Placebo
- +2 more
-
Taipei, TaiwanTaipei Veteran General Hospital (TVGH)
Jun 2, 2022
Febuxostat After Recent Changes in the Prescribing Information
Completed
- Gout
- Cardiovascular Diseases
-
Cambridge, MassachusettsCentral Contact
Apr 23, 2021
Gout Trial in Taipei (Stepwise dose titration of febuxostat and low-dose colchicine, Fixed dose febuxostat and low-dose
Recruiting
- Gout
- Stepwise dose titration of febuxostat and low-dose colchicine
- Fixed dose febuxostat and low-dose colchicine
-
Taipei, TaiwanNational Taiwan University Hospital
Jan 24, 2021
Nonalcoholic Fatty Liver Disease Trial in Ningbo (febuxostat treatment, lifestyle intervention)
Not yet recruiting
- Nonalcoholic Fatty Liver Disease
- febuxostat treatment
- lifestyle intervention
-
Ningbo, Zhejiang, ChinaNingbo first hospital
Feb 24, 2021
Gout Patients Trial in Christchurch (Group 1: AR882 Alone and in Combination with Febuxostat (FBX), Group 2: AR882 Alone and in
Completed
- Gout Patients
- Group 1: AR882 Alone and in Combination with Febuxostat (FBX)
- Group 2: AR882 Alone and in Combination with Allopurinol (ALLO)
-
Christchurch, New ZealandChristchurch Clinical Studies Trust, Ltd (CCST)
Nov 18, 2020
Hyperuricemia Trial in Guangzhou (Febuxostat, Placebo)
Recruiting
- Hyperuricemia
- Febuxostat
- Placebo
-
Guangzhou, Guangdong, ChinaThe First Affiliated Hospital of Sun Yat-sen University
Oct 20, 2020
Hyperuricemia and Diabetic Nephropathy
Not yet recruiting
- Hyperuricemia
- Diabetic Nephropathies
- Febuxostat
- (no location specified)
Mar 12, 2021
Hyperuricemia, Metabolic Syndrome, Left Ventricular Diastolic Dysfunction Trial in Taipei (Febuxostat 40 mg, Benzbromarone 50mg,
Unknown status
- Hyperuricemia
- +2 more
- Febuxostat 40 mg
- +2 more
-
Taipei, Songshan Dist., TaiwanTri-service General Hospital, songshan branch
Apr 26, 2020
Hyperuricemia Trial (SHR4640 dose1 plus Febuxostat dose1, SHR4640 dose1 plus Febuxostat dose2, SHR4640 dose2 plus Febuxostat
Unknown status
- Hyperuricemia
- SHR4640 dose1 plus Febuxostat dose1
- +2 more
- (no location specified)
Nov 28, 2019
Uric Acid Stones, Hyperuricemia Trial in Shanghai (Febuxostat, Uralyt-U)
Unknown status
- Uric Acid Stones
- Hyperuricemia
- Febuxostat
- Uralyt-U
-
Shanghai, Shanghai, ChinaDepartment of Nephrolgoy, Shanghai 10th People's Hospital
Apr 16, 2020
Prehypertension, Gout, Pulse Wave Velocity Trial in San Diego (Febuxostat)
Completed
- Prehypertension
- +4 more
- Febuxostat
-
San Diego, CaliforniaUniverisity Of California San Diego
Nov 26, 2019
Healthy Volunteers Trial in Melbourne (Cohort 1: AR882, Cohort 2: AR882, Cohort 3: AR882)
Completed
- Healthy Volunteers
- Cohort 1: AR882
- +8 more
-
Melbourne, Victoria, AustraliaNucleus Network Pty, Ltd.
Nov 12, 2020